These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31932275)

  • 1. Clinical Features and Disease Management in Adult Patients With Atopic Dermatitis Receiving Care at Reference Hospitals in Brazil: the ADAPT Study.
    Arruda LK; Yang AC; Aoki V; Criado RF; Pires MC; Lupi O; Fabricio LH; Richman D; Silvi S
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):236-245. PubMed ID: 31932275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atopic dermatitis is an important comorbidity in severe asthma.
    Lee JK; Han D
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):661-662. PubMed ID: 29496463
    [No Abstract]   [Full Text] [Related]  

  • 3. Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A serie of cases.
    García M; Durán-Crane A; Chapman E; García E
    Rev Alerg Mex; 2019; 66(3):282-291. PubMed ID: 31606011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial.
    Chan S; Cornelius V; Chen T; Radulovic S; Wan M; Jahan R; Lack G
    Trials; 2017 Mar; 18(1):136. PubMed ID: 28330497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omalizumab for the treatment of atopic dermatitis.
    Fernández-Antón Martínez MC; Leis-Dosil V; Alfageme-Roldán F; Paravisini A; Sánchez-Ramón S; Suárez Fernández R
    Actas Dermosifiliogr; 2012 Sep; 103(7):624-8. PubMed ID: 22056257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis Registry.
    Silverberg JI; Pierce E; Feely M; Atwater AR; Schrader A; Jones EA; Dave SS; Simpson EL
    J Dermatolog Treat; 2023 Dec; 34(1):2246601. PubMed ID: 37691405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atopic dermatitis in adults: clinical and epidemiological considerations.
    Orfali RL; Shimizu MM; Takaoka R; Zaniboni MC; Ishizaki AS; Costa AA; Tiba AP; Sato MN; Aoki V
    Rev Assoc Med Bras (1992); 2013; 59(3):270-5. PubMed ID: 23680276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease.
    Megna M; Patruno C; Balato A; Rongioletti F; Stingeni L; Balato N;
    Arch Dermatol Res; 2017 Aug; 309(6):443-452. PubMed ID: 28432437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study.
    Sheinkopf LE; Rafi AW; Do LT; Katz RM; Klaustermeyer WB
    Allergy Asthma Proc; 2008; 29(5):530-7. PubMed ID: 18926061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy.
    Velling P; Skowasch D; Pabst S; Jansen E; Tuleta I; Grohé C
    Eur J Med Res; 2011 Sep; 16(9):407-10. PubMed ID: 22024441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab for difficult-to-treat dermatological conditions: clinical and immunological features from a retrospective real-life experience.
    Romano C; Sellitto A; De Fanis U; Balestrieri A; Savoia A; Abbadessa S; Astarita C; Lucivero G
    Clin Drug Investig; 2015 Mar; 35(3):159-68. PubMed ID: 25578818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of omalizumab efficacy in severe atopic dermatitis with extremely elevated IgE levels: two case reports and a literature review.
    Nečas M; Vašků V; Březinová E
    Acta Dermatovenerol Alp Pannonica Adriat; 2019 Jun; 28(2):89-92. PubMed ID: 31233174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on Atopic Dermatitis.
    Torres T; Ferreira EO; Gonçalo M; Mendes-Bastos P; Selores M; Filipe P
    Acta Med Port; 2019 Sep; 32(9):606-613. PubMed ID: 31493365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of eosinophils, basophils, serum total IgE level, allergen-specific IgE, and clinical features in atopic dermatitis.
    Hu Y; Liu S; Liu P; Mu Z; Zhang J
    J Clin Lab Anal; 2020 Jun; 34(6):e23214. PubMed ID: 32068307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of severe recalcitrant vernal keratoconjunctivitis and atopic dermatitis associated with elevated IgE levels with omalizumab.
    Zengarini C; Roda M; Schiavi C; Bruni F; Bardazzi F; Bellusci C; Raone B
    Clin Exp Dermatol; 2022 Mar; 47(3):604-606. PubMed ID: 34731495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march.
    Holm JG; Agner T; Clausen ML; Thomsen SF
    Arch Dermatol Res; 2019 Apr; 311(3):173-182. PubMed ID: 30770978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study.
    Bruin-Weller M; Pink AE; Patrizi A; Gimenez-Arnau AM; Agner T; Roquet-Gravy PP; Ferrucci SM; Arenberger P; Svensson A; Schuttelaar MLA; Nosbaum A; Jayawardena S; Rizova E; Ardeleanu M; Eckert L; Ozturk ZE
    J Dermatolog Treat; 2021 Mar; 32(2):164-173. PubMed ID: 33461356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of dietary intake of vitamin E in the treatment of atopic dermatitis: a study of the clinical course and evaluation of the immunoglobulin E serum levels.
    Tsoureli-Nikita E; Hercogova J; Lotti T; Menchini G
    Int J Dermatol; 2002 Mar; 41(3):146-50. PubMed ID: 12010339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast treatment in children with moderately severe atopic dermatitis.
    Ehlayel MS; Bener A; Sabbah A
    Eur Ann Allergy Clin Immunol; 2007 Sep; 39(7):232-6. PubMed ID: 18236999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.